Ananda, Genflow, Greatland Gold, Diversified Energy, Zephyr, Pantheon Resources - Small Cap Snapshot
Published: 09:15 20 Feb 2025 GMT
Ananda Pharma Plc (AQSE:ANA) has hit a key milestone for its cannabidiol-based medicine, MRX1, completing the final technical batch needed for regulatory approval. This is a crucial step toward getting the green light from the UK’s MHRA to start clinical trials.
Genflow Biosciences PLC (LSE:GENF, OTCQB:GENFF) is moving closer to a European patent for its SIRT6 variant, which could help tackle age-related diseases. The European Patent Office has no further questions, allowing the application to move forward.
Greatland Gold PLC (AIM:GGP, OTC:GRLGF) says the first underground drilling results at West Dome are “exceptional.” Sixteen of 19 holes showed strong gold and copper mineralisation beneath the Telfer West Dome open pit.
Diversified Energy Company PLC (LSE:DEC, NYSE:DEC) plans to raise $123.3 million through a US share offering at $14.50 a share. The funds will support its $1.28 billion Maverick Natural Resources acquisition or go toward debt if the deal falls through.
Zephyr Energy PLC (AIM:ZPHR, OTCQB:ZPHRF) has finished drilling at its State 36-2 well in Utah’s Paradox Basin, reaching over 15,000 feet. The well hit the target zone with 97% accuracy, showing strong gas levels throughout.
Finally, Pantheon Resources PLC (AIM:PANR, OTCQX:PTHRF) has named Alaskan energy veteran Max Easley as CEO. The company is preparing for a potential US listing and shifting from exploration to production.
